Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126310 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dora Kolić und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Research and Occupational Health, Ksaverska cesta 2, HR-10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Strobilurins, Cholinesterase Inhibitors, Acetylcholinesterase, Fungicides, Industrial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union - Next Generation EU (Class: 643-02/23-01/00016, Reg. no. 533-03-23-0006), European Regional Development Fund, Education Centre of Environmental Health and Radiation Protection–Reconstruction and Expansion of the Institute for Medical Research and Occupational Health.
Abstract (Originalsprache)
Triazoles are compounds with various biological activities, including fungicidal action. They became popular through cholinesterase studies after the successful synthesis of the dual binding femtomolar triazole inhibitor of acetylcholinesterase (AChE, EC 3.1.1.7) by Sharpless et al. via in situ click chemistry. Here, we evaluate the anticholinesterase effect of the first isopropanol triazole fungicide mefentrifluconazole (Ravystar®), developed to overcome fungus resistance in plant disease management. Mefentrifluconazole is commercially available individually or in a binary fungicidal mixture, i.e., with pyraclostrobin (Ravycare®). Pyraclostrobin is a carbamate that contains a pyrazole ring. Carbamates are known inhibitors of cholinesterases and the carbamate rivastigmine is already in use for the treatment of Alzheimer’s disease. We tested the type and potency of anticholinesterase activity of mefentrifluconazole and pyraclostrobin. Mefentrifluconazole reversibly inhibited human AChE and BChE with a seven-fold higher potency toward AChE (Ki = 101 ± 19 μM). Pyraclostrobin (50 μM) inhibited AChE and BChE progressively with rate constants of (t1/2 = 2.1 min; ki = 6.6 × 103 M−1 min−1) and (t1/2 = 1.5 min; ki = 9.2 × 103 M−1 min−1), respectively. A molecular docking study indicated key interactions between the tested fungicides and residues of the lipophilic active site of AChE and BChE. Additionally, the physicochemical properties of the tested fungicides were compared to values for CNS-active drugs to estimate the blood–brain barrier permeability. Our results can be applied in the design of new molecules with a lesser impact on humans and the environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, HR-10000 Zagreb, Croatia.
ORCID-Profile: Dora Kolić, Goran Šinko
Förderung
- European Union - Next Generation EU (Class: 643-02/23-01/00016, Reg. no. 533-03-23-0006)
- European Regional Development Fund
- Education Centre of Environmental Health and Radiation Protection–Reconstruction and Expansion of the Institute for Medical Research and Occupational Health
- European Union–Next Generation EU
Zitieren
APA
Kolić, D., & Šinko, G. (2024). Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126310
Vancouver
Kolić D, Šinko G. Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126310
BibTeX
@article{Koli2024,
author = {Kolić, Dora and Šinko, Goran},
title = {Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126310}
}
EUVIMED